Instant Access

Objectionable Microorganisms in Biopharmaceutical Manufacturing

4660
Duration60 Minutes
Carl Patterson, MS, SSGB, SSBB
Instructor

Carl Patterson, MS, SSGB, SSBB

View profile

This webinar will discuss the regulations pertaining to objectionable microorganisms, agency expectations, methods to identify objectionable microorganisms, interpreting results, and controls to put into place.

Objectionable microorganisms are considered, if discovered, harmful to the patient. By identifying and controlling these microorganism and putting the appropriate controls into place early in the pharmaceutical or medical device manufacturing process, problems in the patient can be prevented.

Course Objectives:

This webinar will review the regulations pertaining to objectionable microorganisms, testing and identifying objectionable microorganisms, and putting appropriate controls into place to prevent harm to the patient. By knowing, where, when, why, and how objectionable microorganisms exist, harmful consequences to the patient can be prevented.

Course Outline:

• Definition of objectionable microorganisms
• Regulations pertaining to objectionable microorganisms
• Identifying objectionable microorganisms
• Tests to determine objectionable microorganisms
• Sources of objectionable microorganisms
• Actions to reduce objectionable microorganism

What You Get:

• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points

Who Will Benefit:

• Quality Assurance
• Quality Control
• Production
• Logistics
• Manufacturing
• Quality system auditors
• QA directors and managers
• Microbiology analysts and technicians
• Consultants
• Regulatory and Compliance Management

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

100% MONEY BACK GUARANTEED

Refund / Cancellation policy

Get In Touch

Subject : Objectionable Microorganisms in Biopharmaceutical Manufacturing


Similar Trainings

QSR-Compliant Equipment Control & Validation of Processes in the Manufacturing Environment
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program
Biopharmaceutical Aspects of the Active Pharmaceutical Ingredient and Pharmaceutical Equivalence
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program
Good Laboratory Practices (GLPS) Comparing and Contrasting With Good Manufacturing Practices (GMPS)
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program
Bioavailability and Bioequivalence Studies submitted in NDAs and INDs
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program
Veterinary Feed Directive (VFD) Final Rule – What you need to know?
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 60 Minutes
View Program